EA201301340A1 - PHARMACEUTICAL COMPOSITION, HAVING A NEUROPROTECTIVE ACTION, ITS APPLICATION AND METHODS TO IMPROVE VIABILITY AND PREVENTION OR TREATMENT OF CEREBROVASCULAR AND NEURODEGENERATIVE TREATMENTS. - Google Patents

PHARMACEUTICAL COMPOSITION, HAVING A NEUROPROTECTIVE ACTION, ITS APPLICATION AND METHODS TO IMPROVE VIABILITY AND PREVENTION OR TREATMENT OF CEREBROVASCULAR AND NEURODEGENERATIVE TREATMENTS.

Info

Publication number
EA201301340A1
EA201301340A1 EA201301340A EA201301340A EA201301340A1 EA 201301340 A1 EA201301340 A1 EA 201301340A1 EA 201301340 A EA201301340 A EA 201301340A EA 201301340 A EA201301340 A EA 201301340A EA 201301340 A1 EA201301340 A1 EA 201301340A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical composition
cerebrovascular
prevention
treatment
glu
Prior art date
Application number
EA201301340A
Other languages
Russian (ru)
Other versions
EA023025B1 (en
Inventor
Петр Александрович Белый
Евгений Александрович ЧЕРТОРИЖСКИЙ
Михаил Владимирович ОВЧИННИКОВ
Original Assignee
Замертон Холдингс Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Замертон Холдингс Лимитед filed Critical Замертон Холдингс Лимитед
Priority to EA201301340A priority Critical patent/EA023025B1/en
Publication of EA201301340A1 publication Critical patent/EA201301340A1/en
Publication of EA023025B1 publication Critical patent/EA023025B1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение относится к медицине и касается фармацевтической композиции, содержащей пептиды Asp-Glu-Gly, Lys-Asp-Glu и Ala-Asp-Glu-Leu. Композиция обладает выраженным нейропротекторным действием, что позволяет использовать фармацевтическую композицию, содержащую пептиды Ala-Asp-Glu, Lys-Asp-Glu и Ala-Asp-Glu-Leu для профилактики или лечения цереброваскулярных и нейродегенеративных заболеваний, а также для повышения жизнеспособности.The invention relates to medicine and relates to a pharmaceutical composition comprising peptides Asp-Glu-Gly, Lys-Asp-Glu and Ala-Asp-Glu-Leu. The composition has a pronounced neuroprotective effect, which allows the use of a pharmaceutical composition containing the peptides Ala-Asp-Glu, Lys-Asp-Glu and Ala-Asp-Glu-Leu for the prevention or treatment of cerebrovascular and neurodegenerative diseases, as well as to increase viability.

EA201301340A 2013-12-26 2013-12-26 Pharmaceutical composition having a neuroprotective effect, use thereof and methods for enhancing vitality and preventing and/or treating cerebrovascular and neurodegenerative diseases EA023025B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EA201301340A EA023025B1 (en) 2013-12-26 2013-12-26 Pharmaceutical composition having a neuroprotective effect, use thereof and methods for enhancing vitality and preventing and/or treating cerebrovascular and neurodegenerative diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EA201301340A EA023025B1 (en) 2013-12-26 2013-12-26 Pharmaceutical composition having a neuroprotective effect, use thereof and methods for enhancing vitality and preventing and/or treating cerebrovascular and neurodegenerative diseases

Publications (2)

Publication Number Publication Date
EA201301340A1 true EA201301340A1 (en) 2015-06-30
EA023025B1 EA023025B1 (en) 2016-04-29

Family

ID=53488009

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201301340A EA023025B1 (en) 2013-12-26 2013-12-26 Pharmaceutical composition having a neuroprotective effect, use thereof and methods for enhancing vitality and preventing and/or treating cerebrovascular and neurodegenerative diseases

Country Status (1)

Country Link
EA (1) EA023025B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2678987C2 (en) * 2017-04-28 2019-02-05 Общество с ограниченной ответственностью "Научно-производственная фирма ВЕРТА" Peptide for treatment of alzheimer's disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2468813C1 (en) * 2011-08-08 2012-12-10 Градстейн Инвестментс Лимитед Agent for prevention and treatment of acute and chronic cerebrovascular disease, use and method of treating
RU2482128C1 (en) * 2011-12-28 2013-05-20 Замертон Холдингс Лимитед Peptides possessing cytoprotective activity
RU2480233C1 (en) * 2012-02-29 2013-04-27 Замертон Холдингс Лимитед Pharmaceutical composition possessing antihypoxic, neuroprotective and antiamnestic activity

Also Published As

Publication number Publication date
EA023025B1 (en) 2016-04-29

Similar Documents

Publication Publication Date Title
EA201691582A1 (en) NEW PHARMACEUTICAL PREPARATIONS
EA201790932A1 (en) DOSAGE AND ADMINISTRATION OF NONFUCULATED ANTI-CD40 ANTIBODIES
EA201790273A1 (en) FLAGELLIN COMPOSITIONS AND THEIR APPLICATION
EA201991484A1 (en) MEDICINAL FORMS OF ENZALUTAMIDE
EA201591166A1 (en) AUTOTAXIN INHIBITORS
EA201591616A1 (en) TRIFTTOROMETHYL-SUBSTITUTED ANNELATED PYRIMIDINES AND THEIR APPLICATION
EA201691845A1 (en) PHARMACEUTICAL COMPOSITIONS OF THERAPEUTICALLY ACTIVE COMPOUNDS
EA201591925A1 (en) THERAPEUTIC COMPOSITIONS AND THEIR APPLICATION
EA201790575A1 (en) TRIAZOLOPIRASINONS AS PDE1 INHIBITORS
EA202090098A1 (en) PHARMACEUTICAL COMPOSITIONS OF THERAPEUTICALLY ACTIVE COMPOUNDS
EA201692109A1 (en) OPTIONS OF ANTIBODIES TO FACTOR D AND THEIR APPLICATION
EA201790576A1 (en) Spirocyclic inhibitors of katepsin C
EA201692007A1 (en) IZOINDOLINON COMPOUNDS AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA, AND RELATED DISORDERS
EA201691481A1 (en) C5a inhibitors for the treatment of viral pneumonia
AR101740A1 (en) COMBINATION AND COMPOSITION THERAPY
EA201690159A1 (en) METHODS AND COMPOSITIONS FOR CANCER TREATMENT
EA201792157A1 (en) IMIDAZOPIRASINONS AS PDE1 INHIBITORS
EA201690039A1 (en) RORC2 INHIBITORS AND METHODS OF THEIR APPLICATION
PH12017500304A1 (en) Vaccine compositions against dengue virus diseases
EA201690783A1 (en) SUBSTANCES, PHARMACEUTICAL COMPOSITION AND METHODS OF APPLICATION IN THE TREATMENT OF INFLAMMATORY DISEASES
EA201491500A1 (en) FIBROZA TREATMENT METHODS
EA201791249A1 (en) CD44V6-RECEIVED CYCLIC PEPTIDES FOR THE TREATMENT OF MALIGNANT TUMORS AND ANGOGENESIS-ASSOCIATED DISEASES
CO2017001087A2 (en) Anti angiopoietin-like protein 4 antibodies
EA201792571A1 (en) THERAPEUTIC APPLICATION OF L-4-CHLOROKINURENIN
MX2019001634A (en) Amide compounds, pharmaceutical compositions thereof, and methods of using the same.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): KG TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ RU

NF4A Restoration of lapsed right to a eurasian patent

Designated state(s): AM AZ BY KZ RU

PC4A Registration of transfer of a eurasian patent by assignment